# RMTI catalysts: ROCKWELL MEDICAL, INC. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/rmti/catalysts

> ROCKWELL MEDICAL, INC. (RMTI) has no upcoming catalysts in this calendar. The latest recorded is the ROCKWELL MEDICAL, INC. earnings report, November 12, 2026.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Company

| Field | Value |
| --- | --- |
| Name | ROCKWELL MEDICAL, INC. |
| Ticker | RMTI (Nasdaq) |
| SEC CIK | 1041024 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/rmti |

## Cash runway

Cash $10.6M as of 2026-09-30; quarterly burn $1.5M; about 20.9 months of runway at that rate (XBRL company facts, accession 0001628280-26-073086).

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| April 25, 2016 | [Triferic Avnu (ferric pyrophosphate citrate) FDA approval](https://sec-api.dev/pdufa/ferric-pyrophosphate) | RMTI |  | completed, approved | "NDA208551 ORIG-1 (Type 3 - New Dosage Form): submission_status AP, submission_status_date 20160425, review_priority STANDARD; sponsor_name ROCKWELL MEDICAL INC; product TRIFERIC (FERRIC PYROPHOSPHATE CITRATE)." ([openFDA Drugs@FDA](https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208551%22)) |
| March 27, 2020 | [Triferic Avnu (ferric pyrophosphate citrate) FDA approval](https://sec-api.dev/pdufa/ferric-pyrophosphate) | RMTI |  | completed, approved | "NDA212860 ORIG-1 (Type 3 - New Dosage Form): submission_status AP, submission_status_date 20200327, review_priority STANDARD; sponsor_name ROCKWELL MEDICAL INC; product TRIFERIC AVNU (FERRIC PYROPHOSPHATE CITRATE)." ([openFDA Drugs@FDA](https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA212860%22)) |
| November 12, 2024 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Wixom, Michigan, November 12, 2024 - Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and nine months ended September 30, 2024." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000162828024046792/rmtiq324earningspr-final8k.htm)) |
| March 20, 2025 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Michigan, March 20, 2025 - Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three months and twelve months ended December 31, 2024." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000110465925025782/tm259810d1_ex99-1.htm)) |
| May 12, 2025 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Michigan, May 12, 2025 - Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three months ended March 31, 2025." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000110465925046957/tm2514651d1_ex99-1.htm)) |
| August 14, 2025 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Rockwell Medical Announces Second Quarter 2025 Results" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000104102425000009/pressrelease.htm)) |
| November 12, 2025 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Rockwell Medical Announces Third Quarter 2025 Results" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000162828025051267/a2025q3earningspr.htm)) |
| January 20, 2026 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000162828026002478/a2025q4fy25prereleasepr.htm)) |
| March 26, 2026 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Wixom, Michigan, March 26, 2026 - Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and twelve months ended December 31, 2025." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000162828026021176/a2025q4fy-earningsxpr.htm)) |
| May 7, 2026 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000162828026031629/a2025q1-26xearningsxpr.htm)) |
| August 13, 2026 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Rockwell Medical Announces Second Quarter 2026 Results" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000162828026056454/a2026q2-26xearningsxpr.htm)) |
| November 12, 2026 | [ROCKWELL MEDICAL, INC. earnings report](https://sec-api.dev/companies/rmti/catalysts) | RMTI |  | completed | "Rockwell Medical Announces Third Quarter 2026 Results" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1041024/000162828026073052/a2026q326-earningsxpr.htm)) |

## Drugs

- [Triferic Avnu (ferric pyrophosphate citrate)](https://sec-api.dev/pdufa/ferric-pyrophosphate): 

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/rmti/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "RMTI catalysts: ROCKWELL MEDICAL, INC. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/rmti/catalysts

```bibtex
@misc{secapidev_companies_rmti_catalysts_20261116,
  title        = {RMTI catalysts: ROCKWELL MEDICAL, INC. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/rmti/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_rmti_catalysts_20261116","title":"RMTI catalysts: ROCKWELL MEDICAL, INC. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/rmti/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
